Ono Pharmaceutical Co Ltd 2024 IR

The report highlights Ono Pharmaceutical's performance for the fiscal year ended March 31, 2024, during which the company achieved record-high revenue of 502.7 billion yen and operating profit of 159.9 billion yen. Key milestones included exceeding 100 billion yen in R&D investment for the first time and acquiring Deciphera Pharmaceuticals to accelerate global development and direct sales in the U.S. and Europe. The company also made progress on its environmental goals under ECO VISION 2050, reducing Scope 1 and 2 greenhouse gas emissions by 46.2% compared to FY2017. Additionally, Ono implemented a new global human resource system to support its transition into a Global Specialty Pharma.

Company: Ono Pharmaceutical Co Ltd

Sector: Health Care

Country: Japan

Year: 2024

Type: IR

Pages: 100

Back to company

Ono Pharmaceutical Co Ltd

Ono Pharmaceutical Co Ltd 2024 Corporate Report

Corporate Report

The report highlights Ono Pharmaceutical's performance for the fiscal year ended March 31, 2024, during which the company achieved record-high revenue of 502.7 billion yen and operating profit of 159.9 billion yen. Key milestones included exceeding 100 billion yen in R&D investment for the first time and acquiring Deciphera Pharmaceuticals to accelerate global development and direct sales in the U.S. and Europe. The company also made progress on its environmental goals under ECO VISION 2050, reducing Scope 1 and 2 greenhouse gas emissions by 46.2% compared to FY2017. Additionally, Ono implemented a new global human resource system to support its transition into a Global Specialty Pharma.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Apr 1, 2023 - Mar 31, 2024

Fiscal Year

2024

Published

Sep 1, 2024

Type

Integrated Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Net Zero Target

Employees